PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,770.50
Bid: 1,770.50
Ask: 1,771.50
Change: -13.00 (-0.73%)
Spread: 1.00 (0.056%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK MORNING BRIEFING: Glencore Sells Interest In Peru Copper Project

Mon, 14th Apr 2014 07:15

LONDON (Alliance News) - Glencore Xstrata said Monday it has agreed to sell its interest in the Las Bambas copper project in Peru to a Chinese consortium including MMG, Guoxin International Investment Corp and CITIC Metal Co for USD5.85 billion in cash.

The deal is part of an agreement to win Chinese regulatory approval for its USD29 billion takeover of Anglo-Swiss miner Xstrata in May last year

In UK economic news, UK house prices rose to a record high due to the lack of property coming for sale in April, data from the property tracking website Rightmove showed. Asking prices increased at a pace of 7.3% year-on-year in April, the highest since October 2007 and takes it back to pre-credit crunch levels.

Here is what you need to know at the UK market open:

----------

MARKETS

----------

FTSE 100: Down 0.3% at 6,541.79

FTSE 250: Down 0.3% at 15,848.96

AIM ALL-SHARE: Flat at 835.06

----------

Hang Seng: Up 0.1% at 23,034.01

Nikkei 225: Closed down 0.4% at 13,910.16

DJIA: Closed down 0.9% at 16,026.75

S&P 500: Closed down 1.0% at 1815.69

Nasdaq: Closed down 1.3% at 3,999.734

----------

GBP-USD: Down at USD1.6733

EUR-USD: Down at USD1.3848

GOLD: Up at USD1,328.43 per ounce

OIL (Brent): Up at USD108.19 a barrel

(changes since end of previous GMT day)

----------

ECONOMICS AND GENERAL

----------

Monday's Key Economic Events still to come

(all times British Summer Time)

09:00 Italy Consumer Price Index

10:00 EU Industrial Production

13:30 US Retail Sales

15:00 US Business Inventories

17:45 EU ECB Governing Council Member Noyer speech

----------

UK house prices rose to a record high due to the lack of property coming for sale in April, data from the property tracking website Rightmove showed. Asking prices increased at a pace of 7.3% year-on-year in April, the highest since October 2007 and takes it back to pre-credit crunch levels. This follows a 6.8% rise reported for March. The availability of mortgage finance coupled with property shortages exacerbated house prices. The monthly growth held steady at 2.6% in April.

----------

Pro-Russian separatists must lay down their weapons and leave the police stations and administrative buildings in eastern Ukraine they are occupying or a large-scale army operation will be launched against them, Ukraine's president said. The separatists had until 9 am (0600 GMT) to meet the demands, Turchynov said, adding that he had signed a decree promising they would not face prosecution unless they had fired upon Ukrainian security forces.

----------

Syrian President Bashar al-Assad has suggested that the more than three-year-old civil war in his country is tilting in favour of his government. "There is a turning point in the Syrian crisis. Militarily, the army has made successive accomplishments in the war against terrorism," he told a gathering of students in the capital Damascus, according to Syria's official news agency SANA. While al-Assad has faced an unprecedented rebellion since 2011, his troops, backed by fighters from the allied Lebanese Shiite Movement Hezbollah, have in recent months regained opposition-held strongholds, mainly near the border with Lebanon.

----------

Turkey Prime Minister Recep Tayyip Erdogan has lashed out at the head of the Constitutional Court, as tensions rise between the country's chief judicial body and the government. In a veiled reference to Hasim Kilic, the head of the court, Erdogan called for a judge who wants to get involved in politics to "take off your robe." The court this week issued a ruling overturning key parts of a controversial new law that gave the justice minister more power over the judiciary, which civil rights groups argued risked politicizing the justice system.

----------

BROKER RATING CHANGES

---------

UBS CUTS ASHMORE GROUP TO 'NEUTRAL' ('BUY') - TARGET 350 (355) PENCE

----------

TRADERS: NUMIS RAISES JARDINE LLOYD THOMPSON TO 'ADD' ('HOLD')

----------

COMPANIES - FTSE 100

----------

Swiss commodities trader and miner Glencore Xstrata has agreed to sell its interest in the Las Bambas copper project in Peru to a Chinese consortium including MMG, Guoxin International Investment Corp and CITIC Metal Co for USD5.85 billion in cash. The consortium will reimburse all capital expenditure and other costs incurred in developing Las Bambas during the period between January 1 and the closing of the deal. As of the end of March, the capital expenditure and other costs incurred since January 1 stood at about USD400 million. Glencore is selling the Las Bambas project as part of an agreement to win Chinese regulatory approval for its USD29 billion takeover of Anglo-Swiss miner Xstrata in May last year.

----------

UK-based drugmaker GlaxoSmithKline is facing a criminal probe in Poland for allegedly paying bribes to doctors to promote its asthma drug Seretide, BBC Panorama reported on Sunday. According to the report, eleven doctors and one of Glaxo's regional managers have been charged over alleged corruption between 2010 and 2012. The doctors were reportedly bribed to promote Seretide.

----------

Japan-based Orix Corp is considering bidding for Asia-focused lender Standard Chartered's consumer credit unit in Hong Kong, Bloomberg reported citing two people familiar matter. Orix may seek to team up with another investor to acquire PrimeCredit Ltd. Standard Chartered wants to sell the unit for about USD700 million, almost three times book value, and plans to compile a shortlist of potential bidders this month, the report said quoting the people.

----------

COMPANIES - ALL-SHARE AND AIM

----------

Quintain Estates & Developments has created a joint venture with Keystone Developers SA, a subsidiary of Swiss private equity business Keystone Group Holdings, to deliver the next phase of its residential development at Wembley Park. Earlier this year, the London property investment and development specialists secured planning permission for 475 apartments near Wembley Park in North London.

----------

Punch Taverns has brought in an independent corporate restructuring expert to aid long-running discussions over its GBP2.3 billion debt mountain, The Sunday Telegraph reported without saying where it got the information. Dean Merritt, from Talbot Hughes McKillop, is representing the companies that issued Punch?s debt, amid hopes a deal that is agreeable to all lenders and shareholders can be thrashed out by the beginning of next month, the newspaper reports.

----------

Carr's Milling Industries H1 Pretax Profit GBP10.1M Vs GBP9.9M, H1 Revenue GBP214.7M Vs GBP231.6M, Interim Dividend 8.5p Vs 7.75p, To Meet FY Expectations, Says H2 Has Begun Well.

----------

Pentagon Protection is in talks with several parties about providing short term financing or other alternatives, to alleviate constraints on its working capital. Although it has a "relatively health sales pipeline" in each of its divisions, Pentagon said the timing of contract milestones and the conversion of new contracts has led to a deterioration in its cash.

----------

Iodine producer Iofina has started production at two more extraction plants after getting the necessary regulatory approval. In a statement, the company said it has started production at IO#4 and IO#5. The company is constructing a sixth plant based on its wellhead extraction IoSorb technology, IO#6, and expects it to be completed in the second quarter of 2014. However, last month it said that would be the last plant to be built until it has completed a review that it hopes will improve its construction methods and reduce build costs.

----------

32Red has signed a three-year sponsorship agreement with Rangers International Football Club starting from the 2014/2015 season. The deal includes shirt sponsorship, extensive visibility at the club's ground and on its media platforms.

----------

SCISYS has won an operations contract with GMV Aerospace and Defence to provide the mission operations facility of a new geostationary weather satellite. The company said the expected value of the contract is about EUR1.8 million over the next six years, starting in the current reporting period.

----------

MP Evans FY Profit USD22.9M Vs USD21.6M, Raises Dividend To 8.25P, Up 0.25P, Says Price Prospects For Palm Oil, Beef Cattle Remain Favourable

----------

Networkers Intl FY Adjusted Pretax Profit GBP7.1M Vs GBP7.0M, FY Pretax Profit GBP6.3M Vs GBP5.7M, Final Dividend Up 54% To 1.00P, Total Dividend 1.70P Vs 1.25P

----------

Brooks Macdonald Group has acquired Jersey-based DPZ Capital Ltd from DPZ Holdings Ltd for up to GBP13.0 million, including about GBP1.0 million of net current assets, in a move designed to bolster the wealth manager's discretionary funds under management and international presence. The AIM-listed wealth manager said the acquisition increases pro forma discretionary funds under management by GBP360.0 million to GBP6.04 billion.

----------

Real Estate Investors has acquired 33 Bennetts Hill in Birmingham city centre for GBP1.6 million in cash from commercial property consultants GVA, acting on behalf of Royal Bank of Scotland Group PLC. The West Midlands-based property group said the listed building comprises 8,127 square feet and was formerly the original branch of Midlands Bank.

----------

Omega Diagnostics Group says it met expectations for its last financial year, with revenues and adjusted pretax profit ahead of the previous year. The medical diagnostics company expects to post revenues of GBP11.6 million for the year to end-March, up from GBP11.3 million a year earlier, as a strong performance in its food intolerance division offset declines in its allergy and autoimmune division and its infectious disease division. It expects pretax profit, excluding acquisition costs, share based payments and amortisation, to be around GBP1.1 million, up from GBP276,224 in the previous year.

----------

StratMin Global Resources Has Repaid Its GBP750,000 Darwin Convertible Loan Instrument, Says It Wont Draw Down On Second Trache Of Its Darwin Convertible Loan Instrument

----------

Ortac Resources Says Rock Chip Sampling in Eritrea Shows Gold Up To 23 Grammes per Tonne

----------

Monday's Scheduled AGMs/EGMs

Novae Group

----------

By Steve McGrath; steve.mcgrath@alliancenews.com; @stevemcgrath1

Copyright © 2014 Alliance News Limited. All Rights Reserved.

More News
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.